Exabis Library
Welcome to the e-CCO Library!
P726: Trough levels of infliximab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn’s disease on infliximab maintenance therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P727 Small bowel capsule endoscopy impact on therapeutic decisions in established Crohn’s disease: Analysis of a real-world data
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P727: Change in Crohn's disease behavior in a prospective European population-based inception cohort – the ECCO-EpiCom cohort
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P727: Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P727: Efficacy of vedolizumab (VDZ) by disease localisation in Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P727: Quality of life and disease activity in children and adolescents with inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P728 Comparative assessment of faecal microbiota transplantation and current therapies as induction treatment for active refractory ulcerative colitis: A systematic review and network meta-analysis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P728: Changes in the use of biologics in the treatment of IBD patients over time. Results from a comprehensive Norwegian registry study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P728: Effectiveness and quality of life (QoL) of Ustekinumab (UST) therapy in a Real-world Setting in Germany – First Results of the RUN-CD Study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P728: Efficacy of anti-TNF treatment in patients with refractory ulcerative proctitis: Results from a French retrospective multi-centre national cohort
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P728: Real world evidence for adalimumab biosimilar, MSB 11022, therapy in inflammatory bowel diseases: Adherence analysis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P729 The SAPPHIRE registry: Safety of immunosuppression in a prospective cohort of inflammatory bowel disease patients with a HIstoRy of CancEr
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P729: A ‘real-world’ retrospective multi-centre study comparing infliximab and adalimumab for the maintenance of remission in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P729: Evaluation of hepatobiliary pathologies using transient elastography in patients with inflammatory bowel disease: What about the effect of drugs?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P729: Faecal calprotectin and faecal immunochemical test have different values depending on mucosal status in patients with ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P729: Increased requirement for steroids, thiopurines and intestinal surgery in Crohn's patients who are smokers at IBD diagnosis; a nationwide population based study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P730 Effectiveness and safety of endoscopic balloon dilation of colorectal strictures in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P730: Anti tumor necrosis factor treatment in Ulcerative Colitis: Real-world data and evaluation of current treatment targets (STRIDE II)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P730: Disease phenotype of Korean paediatric Crohn's disease patients at diagnosis: a multicentre retrospective comparative study with EUROKIDS
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P730: High-dosed intravenous iron replacement therapy does not hinder drug-induced amelioration of disease activity in IBD patients with iron deficiency anaemia
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM